Literature DB >> 25940596

Detection of enterotoxigenic E. coli in hospitalised children with and without diarrhoea in Blantyre, Malawi.

Eamonn Trainor1, Miren Iturriza-Gómara1, Bagrey Ngwira2, Nigel Cunliffe1.   

Abstract

BACKGROUND: Enterotoxigenic E. coli (ETEC) is an important cause of diarrhoea among children in developing countries. The burden of ETEC infection was investigated for the first time in children in Malawi.
METHODS: Faecal samples obtained from children < 5 years of age hospitalised with diarrhoea in Blantyre, Malawi over a 10-year period (1997-2007) before introduction of the rotavirus vaccine were examined by PCR for ETEC heat-labile (LT) and heat-stable (STh and STp) enterotoxins. Children hospitalised without diarrhoea were enrolled over a 2-year period as a comparison group.
RESULTS: ETEC was detected in 205 (10.6%) of 1941 children with diarrhoea. The most prevalent toxin type was STh (6·6%), followed by LT (2·1%) and STp (0·9%). ETEC infection was most prevalent in infants aged 6-11 months. Co-infection with rotavirus was common. ETEC was detected in 37 (7·3%) of 507 children without diarrhoea.
CONCLUSION: The burden of ETEC infection in young Malawian children is substantial and should become a focus of diarrhoea prevention efforts in the post-rotavirus vaccine era.

Entities:  

Keywords:  Co-infection; ETEC; Gastro-enteritis; Malawi

Mesh:

Substances:

Year:  2016        PMID: 25940596     DOI: 10.1179/2046905515Y.0000000014

Source DB:  PubMed          Journal:  Paediatr Int Child Health        ISSN: 2046-9047            Impact factor:   1.990


  1 in total

1.  Novel multiplex real-time PCR assays reveal a high prevalence of diarrhoeagenic Escherichia coli pathotypes in healthy and diarrhoeal children in the south of Vietnam.

Authors:  Vu Thuy Duong; Le Thi Phuong Tu; Ha Thanh Tuyen; Le Thi Quynh Nhi; James I Campbell; Pham Van Minh; Hoang Le Phuc; Tran Thi Hong Chau; Nguyen Minh Ngoc; Lu Lan Vi; Claire Jenkins; Iruka Okeke; Ellen Higginson; Stephen Baker
Journal:  BMC Microbiol       Date:  2020-07-03       Impact factor: 4.465

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.